Haldol decanoate and thyroid disease
Jefferson, J.W.
Journal of Clinical Psychiatry 49(11): 457-458
1988
ISSN/ISBN: 0160-6689 PMID: 3182741 Document Number: 318061
Document emailed within 1 workday
Related Documents
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824J. Gilmour'; Blownlee, Y.; Foster, P.; Geekie, C.; Kelly, P.; Robeltson, S.; Wade, E.; H-Braun, B.; Staub, U.; Michel, G.; J.H. Lazarus and A.B. Parkes 2000: The Quantitative Measurement of Autoantibodies to Thyroglobulin and Thyroid Peroxidase by Automated Microparticle Based Immunoassays in Hashimoto's Disease, Graves' Disease and a Follow-Up Study on Postpartum Thyroid Disease Clinical Laboratory 46(1-2): 57-61
Paolucci, S.; Buttinelli, C.; Ciani, S.; Fiume, S. 1982: 2 cases of Gilles de la Tourette's disease treated with haloperidol decanoate Minerva Psichiatrica 23(1): 59-61
Freudenreich, O.; McEvoy, J.P. 1995: How much haldol D does Larry really need? Journal of Clinical Psychiatry 56(7): 331-332
Heimann, P.; Nilsson, O.; Hansson, G. 1970: Parathyroid and thyroid disease. II. Thyroid disease connected with hyperparathyroidism Acta Chirurgica Scandinavica 136(2): 143-146
Khalid, B.A.; Hamilton, N.T.; Cauchi, M.N. 1976: Binding of thyroid microsomes by lymphocytes from patients with thyroid disease and normal subjects Clinical and Experimental Immunology 23(1): 28-32
Schlienger, J.L.; Kieffer, P.; Cherfan, J.; Tempe, J.D. 1987: Coexistence of low thyroid hormone blood levels and decrease in thyrotropin in cases of severe non-thyroid disease Presse Medicale 16(16): 778-779
Mullins, R.J.; Chernajovsky, Y.; Dayan, C.; Londei, M.; Feldmann, M. 1994: Transfection of thyroid autoantigens into EBV-transformed B cell lines. Recognition by Graves' disease thyroid T cells Journal of Immunology 152(11): 5572-5580
Karalus, M.; Tamatea, J.A.; Conaglen, H.M.; Meyer-Rochow, G.Y.; Conaglen, J.V.; Elston, M.S. 2018: Rates of unsuspected thyroid cancer in multinodular thyroid disease New Zealand Medical Journal 131(1468): 69-74
Ursu, H.I.; Dumitriu, L.; Grigorie, D.; Simescu, M.; Vaida, E.; Belgun, M.; Popovici, D. 1993: Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease) Romanian Journal of Endocrinology 31(3-4): 155-163
Felt, V. 1970: Activity of the thyroid gland and treatment of thyroid disease in old age Review of Czechoslovak Medicine 16(3): 118-123
Hirooka, Y.; Li, C.; Takagi, J.; Gotoh, M.; Habu, S.; Yasaka-Nomura, T.; Ishihara, R.; Nakasone, Y.; Nakamura, R.; Morikawa, R.; Otake, K.; Nogimori, T.; Ishizuki, Y. 2004: Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease International Journal of Clinical Pharmacology Research 24(4): 111-116
Stevens, B. 1976: The social value of fluphenazine decanoate Acta Psychiatrica Belgica 76(5): 792-804
Genovesi, G.; Paolini, P.; Marcellini, L.; Vernillo, E.; Salvati, G.; Polidori, G.; Ricciardi, D.; de Nuccio, I.; Re, M. 1996: Relationship between autoimmune thyroid disease Rand Alzheimer's disease Panminerva Medica 38(1): 61-63
Lagomarsino, A.J. 1987: Haloperidol decanoate in psychotic patients Acta Psiquiatrica y Psicologica de America Latina 33(3): 181
Saha, B.; Rajadhyaksha, G.C.; Ray, S.K. 2009: Beneficial effects of nandrolone decanoate in wasting associated with HIV Journal of the Indian Medical Association 107(5): 295-299
Zbytovský, J. 1993: Haloperidol decanoate (Janssen) in the treatment of schizophrenia Ceskoslovenska Psychiatrie 89(1): 27-29
Saha, B.; Rajadhyaksha, G.C.; Ray, S.K. 2009: Beneficial effects of nandrolone decanoate in wasting associated with HIV Journal of the Indian Medical Association 107(5): 295-299
Náhunek, K.; Rodová, A.; Svestka, J. 1970: Clinical experience with fluphenazine decanoate in psychoses Activitas Nervosa Superior 12(1): 47-49
Ormea, F.; Gargovic, A. 1973: The dermatotrophic activity of nandrolone decanoate in eczema British Journal of Clinical Practice 27(7): 261-264